WuXi TIDES boosts oli­go, pep­tide of­fer­ings due to a rise in de­mand, with new builds on­go­ing

BARCELONA — Oligonu­cleotide and pep­tide provider WuXi TIDES is in­creas­ing its ser­vice ca­pac­i­ty due to a rise in cus­tomers, par­tic­u­lar­ly from bio­phar­ma com­pa­nies that have as­sets pro­gress­ing in­to the clin­ic, chief busi­ness of­fi­cer Yu Lu said.

WuXi TIDES is ex­pand­ing its pro­duc­tion of oligonu­cleotides and pep­tides, as well as its man­u­fac­tur­ing of prod­ucts that use these ma­te­ri­als, Lu added on the side­lines of the Con­ven­tion of Phar­ma­ceu­ti­cal In­gre­di­ents (CPHI) in Barcelona.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER